Poteligeo

List of products in the National Drug Code with proprietary name poteligeo. This medication is used to treat certain cancers (such as mycosis fungoides, Sezary syndrome). Mogamulizumab-kpkc belongs to a class of drugs known as monoclonal antibodies. It works by changing the action of your own immune system, directing it to attack cancer cells. This effect helps slow or stop the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
42747-761Poteligeo Mogamulizumab-kpkcInjectionIntravenousKyowa Kirin, Inc.Human Prescription Drug